Similar articles

• Outcomes associated with phosphorus binders in men with non-dialysis-dependent CKD.

  Kovesdy CP, Kuchmak O, Lu JL, Kalantar-Zadeh K. Kovesdy CP, et al. Am J Kidney Dis. 2010 Nov;56(5):842-51. doi: 10.1053/j.ajkd.2010.06.011. Epub 2010 Aug 21. Am J Kidney Dis. 2010. PMID: 20728255 Free PMC article.
• [Chronic renal failure causes bone fragility and blood vessel stiffening].

  Keronen S, Martola L, Honkanen E. Keronen S, et al. Duodecim. 2012;128(5):465-74. Duodecim. 2012. PMID: 22486062 Review. Finnish.
• How KDIGO will (or will not) influence the management of hyperphosphatemia.

  Kovesdy CP. Kovesdy CP. Semin Dial. 2011 Jan-Feb;24(1):35-6. doi: 10.1111/j.1525-139X.2010.00824.x. Epub 2011 Feb 11. Semin Dial. 2011. PMID: 21338391 Review. No abstract available.
• [Renal osteodystrophy--more than a mere bone disease].

  Saha H. Saha H. Duodecim. 2001;117(21):2181-7. Duodecim. 2001. PMID: 12184205 Review. Finnish. No abstract available.
• The dietary management of calcium and phosphate in children with CKD stages 2-5 and on dialysis-clinical practice recommendation from the Pediatric Renal Nutrition Taskforce.

  McAlister L, Pugh P, Greenbaum L, Haffner D, Rees L, Anderson C, Desloovere A, Nelms C, Oosterveld M, Paglialonga F, Polderman N, Qizalbash L, Renken-Terhaerdt J, Tuokkola J, Warady B, Walle JV, Shaw V, Shroff R. McAlister L, et al. Pediatr Nephrol. 2020 Mar;35(3):501-518. doi: 10.1007/s00467-019-04370-z. Epub 2019 Oct 30. Pediatr Nephrol. 2020. PMID: 31667620 Free PMC article.